ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CRTX Cortexyme Inc

1.95
0.00 (0.00%)
Last Updated: 19:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 1.91
Ask Price 1.99
News -
Share Name Share Symbol Market Stock Type
Cortexyme Inc CRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.95 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.95
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0 US$ 1.95 USD

Cortexyme Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
70.47M 36.14M - 0 -51.66M -1.43 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cortexyme News

Real-Time news about Cortexyme Inc (NASDAQ): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CRTX Message Board. Create One! See More Posts on CRTX Message Board See More Message Board Posts

Historical CRTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Cortexyme Description

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.

Your Recent History

Delayed Upgrade Clock